Carrier-Induced Hyporesponsiveness to Pneumococcal Conjugate Vaccines: Unraveling the Influence of Serotypes, Timing, and Previous Vaccine Dose

por Dagan, Ron, Jiang, Qin, Juergens, Christine, Trammel, James, Gruber, William C, Scott, Daniel A
Publicado 2020

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence

por Chilson, Erica, Scott, Daniel A., Schmoele-Thoma, Beate, Watson, Wendy, Moran, Mary M., Isturiz, Raul
Publicado 2020

Sequential Administration of PCV13 Followed by PPSV23 Results in a More Robust Immune Response in PPSV23-Naïve Adults Age 60–64 Years

por Chilson, Erica, Atkinson, Bruce, Hall-Murray, Cassandra, Snow, Vincenza, Schmoele-Thoma, Beate, Isturiz, Raúl E, Scott, Daniel A
Publicado 2017

Late onset of injection site reactions after vaccination with the 13-valent pneumococcal conjugate vaccine in adult study populations

por Juergens, Christine, Trammel, James, Shoji, Yasuko, Patterson, Scott, Watson, Wendy, Webber, Chris, Gruber, William C., Scott, Daniel A., Schmoele-Thoma, Beate
Publicado 2018

Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use

por Baxter, Roger, Aukes, Laurie, Pelton, Stephen I, Yee, Arnold, Klein, Nicola P, Gruber, William C, Scott, Daniel A, Center, Kimberly J
Publicado 2020

1104 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Immunogenicity in the Community Acquired Pneumonia Immunization Trial In Adults (CAPiTA)

por Van Deursen, Anna M.M., Sanders, Elisabeth A.M., Webber, Chris, Patton, Michael, Scott, Daniel A., Sidhu, Mohinder, Drews, Wayne, Bonten, Marc
Publicado 2014

1098 The Immunogenicity of PCV13 compared to PPSV23 in Immunocompetent Older Adults with Stable High Risk Conditions

por Schmoele-Thoma, Beate, Jackson, Lisa A., Greenberg, Richard N., Frenck, Robert, Gurtman, Alejandra, Isturiz, Raul, Sundaraiyer, Vani, Gruber, William, Scott, Daniel A.
Publicado 2014

Persistence of antibodies 1 year after sequential administration of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in adults

por Schmoele-Thoma, Beate, van Cleeff, Martin, Greenberg, Richard N., Gurtman, Alejandra, Jones, Thomas R., Sundaraiyer, Vani, Gruber, William C., Scott, Daniel A.
Publicado 2019

Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine when administered to healthy Japanese adults aged ≥50 years: An open-label trial

por Shiramoto, Masanari, Irie, Shin, Juergens, Christine, Yamaji, Masako, Tamai, Satoshi, Aizawa, Masakazu, Belanger, Todd, Gruber, William C, Scott, Daniel A, Schmoele-Thoma, Beate
Publicado 2014

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults

por Shiramoto, Masanari, Hanada, Ryuzo, Juergens, Christine, Shoji, Yasuko, Yoshida, Mizuki, Ballan, Barry, Cooper, David, Gruber, William C, Scott, Daniel A, Schmoele-Thoma, Beate
Publicado 2015

A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United States

por Fitz-Patrick, David, Young Jr, Mariano, Scott, Daniel A., Scully, Ingrid L., Baugher, Gary, Peng, Yahong, Jansen, Kathrin U., Gruber, William, Watson, Wendy
Publicado 2021

Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine Coadministered with a Quadrivalent Influenza Vaccine in Adults 50 Years and Older Previously Vaccinated With...

por Baxter, Roger, Downey, H. Jackson, Patterson, Scott D., Sundaraiyer, Vani, Watson, Wendy, Clarke, Keri, Gruber, William C., Scott, Daniel A., Thompson, Allison, Schmoele-Thoma, Beate
Publicado 2015

Immunogenicity, Safety, and Tolerability of 13-Valent Pneumococcal Conjugate Vaccine Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Recipients of Allogeneic Hematopoi...

por Cordonnier, Catherine, Ljungman, Per, Juergens, Christine, Maertens, Johan, Selleslag, Dominik, Sundaraiyer, Vani, Giardina, Peter C., Clarke, Keri, Gruber, William C., Scott, Daniel A., Schmoele-Thoma, Beate
Publicado 2015

A randomized phase 1/2 study of the safety and immunogenicity of a multivalent pneumococcal conjugate vaccine in healthy adults 50 through 85 years of age

por Essink, Brandon, Peterson, James, Yacisin, Kari, Lal, Himal, Mirza, Sarah, Xu, Xia, Scully, Ingrid L., Scott, Daniel A., Gruber, William C., Jansen, Kathrin U., Watson, Wendy
Publicado 2021

Randomized trial to evaluate the safety, tolerability, and immunogenicity of a booster (third dose) of BNT162b2 COVID-19 vaccine coadministered with 20-valent pneumococcal conjugat...

por Fitz-Patrick, David, Young, Mariano, Yacisin, Kari, McElwee, Kathleen, Belanger, Todd, Belanger, Kelly, Peng, Yahong, Lee, Dung-Yang, Gruber, William C., Scott, Daniel A., Watson, Wendy
Publicado 2023

Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age

por Hurley, Donald, Griffin, Carl, Young, Mariano, Scott, Daniel A, Pride, Michael W, Scully, Ingrid L, Ginis, John, Severs, Joseph, Jansen, Kathrin U, Gruber, William C, Watson, Wendy
Publicado 2020

Immunogenicity of a 20-valent pneumococcal conjugate vaccine in adults 18 to 64 years old with medical conditions and other factors that increase risk of pneumococcal disease

por Sabharwal, Charu, Sundaraiyer, Vani, Peng, Yahong, Moyer, Lisa, Belanger, Todd J., Gessner, Bradford D., Jodar, Luis, Jansen, Kathrin U., Gruber, William C., Scott, Daniel A., Watson, Wendy
Publicado 2022

A randomized, open-label, phase 3 study evaluating safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in Chinese infants and children under 6 years of age

por Chu, Kai, Hu, Yuemei, Pan, Hongxing, Wu, Jingliang, Zhu, Dandan, Young, Mariano M., Luo, Li, Yi, Zhuobiao, Giardina, Peter C., Gruber, William C., Scott, Daniel A., Watson, Wendy
Publicado 2023

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination

por Bhorat, As’ad E., Madhi, Shabir A., Laudat, France, Sundaraiyer, Vani, Gurtman, Alejandra, Jansen, Kathrin U., Scott, Daniel A., Emini, Emilio A., Gruber, William C., Schmoele-Thoma, Beate
Publicado 2015

Evaluation of a Validated Luminex-Based Multiplex Immunoassay for Measuring Immunoglobulin G Antibodies in Serum to Pneumococcal Capsular Polysaccharides

por Tan, Charles Y., Immermann, Fred W., Sebastian, Shite, Pride, Michael W., Pavliakova, Danka, Belanger, Kelly A., Watson, Wendy, Scott, Daniel A., Sidhu, Mohinder, Jansen, Kathrin U., Giardina, Peter C.
Publicado 2018